These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23499887)

  • 1. Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra.
    Hailey KL; Capraro DT; Barkho S; Jennings PA
    J Mol Biol; 2013 Jul; 425(13):2382-92. PubMed ID: 23499887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical characterization of structural properties and folding of interleukin-1 receptor antagonist.
    Latypov RF; Harvey TS; Liu D; Bondarenko PV; Kohno T; Fachini RA; Rosenfeld RD; Ketchem RR; Brems DN; Raibekas AA
    J Mol Biol; 2007 May; 368(4):1187-201. PubMed ID: 17391700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.
    Gabner S; Ertl R; Velde K; Renner M; Jenner F; Egerbacher M; Hlavaty J
    J Gene Med; 2018 May; 20(5):e3021. PubMed ID: 29608232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease.
    Maeda S; Ohno K; Nakamura K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Goto-Koshino Y; Fujino Y; Tsujimoto H
    Vet J; 2012 Oct; 194(1):66-70. PubMed ID: 22483380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection.
    Liu S; Xu GY; Johnson KM; Echetebu C; Ye ZS; Hulsebosch CE; McAdoo DJ
    Brain Res; 2008 Sep; 1231():63-74. PubMed ID: 18675261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
    Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
    Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.
    McNamee EN; Ryan KM; Kilroy D; Connor TJ
    Eur J Pharmacol; 2010 Jan; 626(2-3):219-28. PubMed ID: 19818755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite regulation of IL-1beta and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells.
    Molnarfi N; Gruaz L; Dayer JM; Burger D
    J Immunol; 2007 Jan; 178(1):446-54. PubMed ID: 17182583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Interleukin 1 Receptor Antagonist Gene on Stable Expression Bone Marrow Mesenchymal Stem Cells and Early Aseptic Loosening of Hip Prosthesis of Mouse.
    Wang Y; Li G; Ma J; Ji B; Aishajiang A; Yelborati B; Cao L
    Mol Biotechnol; 2021 Mar; 63(3):232-239. PubMed ID: 33464542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.
    Olofsson PS; Sheikine Y; Jatta K; Ghaderi M; Samnegård A; Eriksson P; Sirsjö A
    Circ J; 2009 Aug; 73(8):1531-6. PubMed ID: 19574724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner.
    Meier RPH; Meyer J; Montanari E; Lacotte S; Balaphas A; Muller YD; Clément S; Negro F; Toso C; Morel P; Buhler LH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
    Powers NE; Swartzwelter B; Marchetti C; de Graaf DM; Lerchner A; Schlapschy M; Datar R; Binder U; Edwards CK; Skerra A; Dinarello CA
    J Biol Chem; 2020 Jan; 295(3):868-882. PubMed ID: 31819009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
    Rider P; Carmi Y; Yossef R; Guttman O; Eini H; Azam T; Dinarello CA; Lewis EC
    J Immunol; 2015 Aug; 195(4):1705-12. PubMed ID: 26157171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma.
    Bartfai T; Sanchez-Alavez M; Andell-Jonsson S; Schultzberg M; Vezzani A; Danielsson E; Conti B
    Ann N Y Acad Sci; 2007 Oct; 1113():173-7. PubMed ID: 17656565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution structure of murine interleukin 1 homologue IL-1F5 reveals unique loop conformations for receptor binding specificity.
    Dunn EF; Gay NJ; Bristow AF; Gearing DP; O'Neill LA; Pei XY
    Biochemistry; 2003 Sep; 42(37):10938-44. PubMed ID: 12974628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity.
    Greenfeder SA; Varnell T; Powers G; Lombard-Gillooly K; Shuster D; McIntyre KW; Ryan DE; Levin W; Madison V; Ju G
    J Biol Chem; 1995 Sep; 270(38):22460-6. PubMed ID: 7673234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?
    Spinello A; Vecile E; Abbate A; Dobrina A; Magistrato A
    J Chem Inf Model; 2019 Jan; 59(1):351-359. PubMed ID: 30586302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A (99m)Tc-labeled dual-domain cytokine ligand for imaging of inflammation.
    Liu Z; wyffels L; Barber C; Hui MM; Woolfenden JM
    Nucl Med Biol; 2011 Aug; 38(6):795-805. PubMed ID: 21843776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
    Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
    J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.